Exelixis, Inc. (EXEL) income statement
NASDAQ · Healthcare · Biotechnology · 1,077 employees · CEO Michael Morrissey
- Price
- $69.39 +4.82%
- Market cap
- $17.4B
- Enterprise value
- $17.3B
- Last report
- Q3 '26 filed 2026-10-29
Exelixis, Inc. (EXEL) reported revenue of $659M for Q3 '26 (+10.2% year on year), operating income of $268M (40.8% of revenue) and net income of $218M. Over the last four quarters revenue was $2.5B.
Income statement
| Income statement | Trend | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $480M | $425M | $637M | $540M | $567M | $555M | $568M | $598M | $599M | $611M | $629M | $659M | |
| Cost of revenue | $21.8M | $21.3M | $17.7M | $17.3M | $20M | $19.2M | $19.5M | $18.6M | $26.5M | $20M | $20.7M | $26.2M | |
| Gross profit | $458M | $404M | $620M | $522M | $547M | $536M | $549M | $579M | $572M | $591M | $608M | $632M | |
| Research & development | $245M | $228M | $211M | $223M | $249M | $212M | $200M | $199M | $213M | $200M | $212M | $209M | |
| Sales & marketing | $40M | $0 | $0 | $0 | $43.5M | $0 | $0 | $0 | $51.7M | $0 | $0 | $0 | |
| General & administrative | $91.4M | $114M | $132M | $0 | $90.8M | $137M | $135M | $124M | $71.3M | $140M | $148M | $155M | |
| Other operating expenses | $0 | $32.8M | $475K | $51.8M | $254K | $0 | $0 | $19.8M | $694K | $0 | $0 | $0 | |
| Operating expenses | $376M | $375M | $344M | $386M | $384M | $349M | $335M | $343M | $337M | $340M | $360M | $364M | |
| Operating income | $81.8M | $29.5M | $276M | $136M | $163M | $187M | $214M | $237M | $235M | $251M | $248M | $268M | |
| Interest income | $21.4M | $19.9M | $17.3M | $18.7M | $21.3M | $19.1M | $16.8M | $15.9M | $17.4M | $16.1M | $14.2M | $14.3M | |
| Other non-operating income (gains on investments, FX ...) | -$21.3M | -$32.8M | -$475K | -$51.8M | -$254K | -$18.8M | -$16.8M | -$15.9M | -$694K | -$16.3M | -$14.3M | -$14.4M | |
| Total non-operating income | $21.3M | $19.8M | $17M | $18.7M | $21.6M | $18.8M | $16.8M | $15.9M | $17.5M | $16.3M | $14.3M | $14.4M | |
| Income before tax | $103M | $49.3M | $293M | $155M | $185M | $206M | $230M | $252M | $253M | $268M | $263M | $283M | |
| Income tax | $17.5M | $12M | $66.7M | $36.8M | $44.9M | $46.1M | $45.6M | $58.8M | $8.16M | $57.2M | $50.6M | $64.7M | |
| Net income | $85.5M | $37.3M | $226M | $118M | $140M | $160M | $185M | $194M | $245M | $210M | $212M | $218M | |
| EPS (basic) | $0.28 | $0.12 | $0.78 | $0.41 | $0.48 | $0.57 | $0.68 | $0.72 | $0.91 | $0.81 | $0.85 | $0.88 | |
| EPS (diluted) | $0.27 | $0.12 | $0.77 | $0.40 | $0.47 | $0.55 | $0.65 | $0.70 | $0.88 | $0.79 | $0.82 | $0.85 | |
| Shares (basic, weighted) | 308M | 301M | 289M | 286M | 285M | 279M | 273M | 268M | 272M | 258M | 251M | 247M | |
| Shares (diluted, weighted) | 313M | 306M | 294M | 291M | 294M | 288M | 284M | 279M | 282M | 267M | 260M | 256M | |
| Depreciation & amortization | $6.53M | $6.38M | $7.33M | $7.45M | $7.64M | $7.35M | $7.34M | $7.42M | $6.95M | $6.95M | $6.98M | $6.94M | |
| EBITDA | $110M | $68.7M | $284M | $195M | $171M | $213M | $238M | $260M | $243M | $275M | $270M | $290M |
| Income statement | Trend | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $191M | $452M | $854M | $968M | $988M | $1.43B | $1.61B | $1.83B | $2.17B | $2.32B | |
| Cost of revenue | $6.55M | $15.1M | $26.3M | $33.1M | $36.3M | $52.9M | $57.9M | $72.5M | $76.2M | $83.7M | |
| Gross profit | $185M | $437M | $827M | $935M | $951M | $1.38B | $1.55B | $1.76B | $2.09B | $2.24B | |
| Research & development | $96M | $112M | $182M | $337M | $548M | $694M | $892M | $1.04B | $910M | $825M | |
| Sales & marketing | $0 | -$32K | $14.8M | $17.9M | $25.1M | $31.8M | $41.6M | $40M | $0 | $51.7M | |
| General & administrative | $116M | $159M | $192M | $210M | $268M | $370M | $418M | $503M | $492M | $467M | |
| Other operating expenses | $0 | $0 | $397K | $680K | $912K | -$184K | -$197K | $1 | $85.3M | $20.5M | |
| Operating expenses | $212M | $272M | $389M | $565M | $841M | $1.1B | $1.35B | $1.59B | $1.49B | $1.36B | |
| Operating income | -$28.1M | $166M | $439M | $369M | $110M | $287M | $201M | $171M | $605M | $872M | |
| Interest income | $2.58M | $4.88M | $12.8M | $28M | $19.9M | $7.67M | $33.1M | $86.5M | $77.2M | $69.2M | |
| Interest expense | $33.1M | $8.68M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Other non-operating income (gains on investments, FX ...) | $9.04M | -$1.2M | -$1.1M | -$28.6M | $0 | -$7.49M | -$32.9M | -$86.6M | -$85.3M | -$20.5M | |
| Total non-operating income | -$42.1M | -$7.33M | $13.2M | $28.6M | $20.8M | $7.49M | $32.9M | $86.6M | $77M | $69M | |
| Income before tax | -$70.2M | $159M | $452M | $398M | $131M | $294M | $234M | $258M | $682M | $941M | |
| Income tax | $0 | $4.35M | -$238M | $77.1M | $19.1M | $63.1M | $52.1M | $49.8M | $160M | $159M | |
| Net income | -$70.2M | $154M | $690M | $321M | $112M | $231M | $182M | $208M | $521M | $783M | |
| EPS (basic) | -$0.28 | $0.52 | $2.32 | $1.06 | $0.36 | $0.73 | $0.57 | $0.65 | $1.80 | $2.88 | |
| EPS (diluted) | -$0.28 | $0.49 | $2.21 | $1.02 | $0.35 | $0.72 | $0.56 | $0.65 | $1.76 | $2.78 | |
| Shares (basic, weighted) | 251M | 294M | 298M | 303M | 308M | 315M | 322M | 318M | 290M | 272M | |
| Shares (diluted, weighted) | 251M | 312M | 313M | 315M | 318M | 322M | 325M | 321M | 296M | 282M | |
| Depreciation & amortization | $1M | $1.19M | $7.77M | $8.35M | $9.14M | $13.6M | $20.9M | $25.7M | $28.8M | $29.1M | |
| EBITDA | -$36.2M | $168M | $447M | $406M | $119M | $308M | $255M | $283M | $719M | $922M |
Standardised from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in USD.
Revenue, operating income and growth
quarterlyMargins
quarterlyCosts as % of revenue
quarterlyThe other statements
Sources
Statements, segment revenue, metrics and estimates are standardised from the company's filings. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-10-02, 10-Q 2026-07-03, 10-Q 2026-04-03, 10-K 2026-01-02, 10-Q 2025-10-03, 10-Q 2025-07-04, 10-Q 2025-04-04, 10-K 2025-01-03, 10-Q 2024-09-27
Data as of 2026-11-02